{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:07:45Z","timestamp":1794506865325,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":28,"publisher":"Springer New York","isbn-type":[{"value":"9781493931118","type":"print"},{"value":"9781493931125","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3112-5_20","type":"book-chapter","created":{"date-parts":[[2015,10,15]],"date-time":"2015-10-15T08:24:28Z","timestamp":1444897468000},"page":"249-260","source":"Crossref","is-referenced-by-count":6,"title":["Hepatic Delivery of Artificial Micro RNAs Using Helper-Dependent Adenoviral Vectors"],"prefix":"10.1007","author":[{"given":"Carol","family":"Crowther","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Mowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Arbuthnot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"20_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp446","volume":"37","author":"A Ely","year":"2009","unstructured":"Ely A, Naidoo T, Arbuthnot P (2009) Efficient silencing of gene expression with modular trimeric Pol II expression cassettes comprising microRNA shuttles. Nucleic Acids Res 37, e91","journal-title":"Nucleic Acids Res"},{"key":"20_CR2","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.1016\/j.bmc.2013.04.073","volume":"21","author":"MD Marimani","year":"2013","unstructured":"Marimani MD, Ely A, Buff MC, Bernhardt S, Engels JW, Arbuthnot P (2013) Inhibition of hepatitis B virus replication in cultured cells and in vivo using 2\u2032-O-guanidinopropyl modified siRNAs. Bioorg Med Chem 21:6145\u20136155","journal-title":"Bioorg Med Chem"},{"key":"20_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.5501\/wjv.v1.i3.79","volume":"1","author":"SA Knoepfel","year":"2012","unstructured":"Knoepfel SA, Centlivre M, Liu YP, Boutimah F, Berkhout B (2012) Selection of RNAi-based inhibitors for anti-HIV gene therapy. World J Virol 1:79\u201390","journal-title":"World J Virol"},{"key":"20_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10142-013-0344-1","volume":"14","author":"S Azimzadeh Jamalkandi","year":"2014","unstructured":"Azimzadeh Jamalkandi S, Azadian E, Masoudi-Nejad A (2014) Human RNAi pathway: crosstalk with organelles and cells. Funct Integr Genomics 14:31\u201346","journal-title":"Funct Integr Genomics"},{"key":"20_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ymthe.2005.10.013","volume":"13","author":"S Carmona","year":"2006","unstructured":"Carmona S, Ely A, Crowther C, Moolla N, Salazar FH, Marion PL, Ferry N, Weinberg MS, Arbuthnot P (2006) Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs. Mol Ther 13:411\u2013421","journal-title":"Mol Ther"},{"key":"20_CR6","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1089\/hum.2008.066","volume":"19","author":"C Crowther","year":"2008","unstructured":"Crowther C, Ely A, Hornby J, Mufamadi S, Salazar F, Marion P, Arbuthnot P (2008) Efficient inhibition of hepatitis B virus replication in vivo, using polyethylene glycol-modified adenovirus vectors. Hum Gene Ther 19:1325\u20131331","journal-title":"Hum Gene Ther"},{"key":"20_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2174\/2211536611201010019","volume":"1","author":"MB Mowa","year":"2012","unstructured":"Mowa MB, Crowther C, Ely A, Arbuthnot P (2012) Efficient silencing of hepatitis B virus by helper-dependent adenovirus vector-mediated delivery of artificial antiviral primary micro RNAs. MicroRNA 1:19\u201325","journal-title":"MicroRNA"},{"key":"20_CR8","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1099\/0022-1317-81-11-2573","volume":"81","author":"WC Russell","year":"2000","unstructured":"Russell WC (2000) Update on adenovirus and its vectors. J Gen Virol 81:2573\u20132604","journal-title":"J Gen Virol"},{"key":"20_CR9","first-page":"195","volume":"343","author":"JG Smith","year":"2010","unstructured":"Smith JG, Wiethoff CM, Stewart PL, Nemerow GR (2010) Adenovirus. Curr Top Microbiol Immunol 343:195\u2013224","journal-title":"Curr Top Microbiol Immunol"},{"key":"20_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/vir.0.003087-0","volume":"90","author":"WC Russell","year":"2009","unstructured":"Russell WC (2009) Adenoviruses: update on structure and function. J Gen Virol 90:1\u201320","journal-title":"J Gen Virol"},{"key":"20_CR11","first-page":"107","volume":"2","author":"J Huard","year":"1995","unstructured":"Huard J, Lochmuller H, Acsadi G, Jani A, Massie B, Karpati G (1995) The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther 2:107\u2013115","journal-title":"Gene Ther"},{"key":"20_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","volume":"132","author":"SN Waddington","year":"2008","unstructured":"Waddington SN, McVey JH, Bhella D, Parker AL, Barker K, Atoda H, Pink R, Buckley SMK, Greig JA, Denby L, Custers J, Morita T, Francischetti IMB, Monteiro RQ, Barouch DH, van Rooijen N, Napoli C, Havenga MJE, Nicklin SA, Baker AH (2008) Adenovirus Serotype 5 hexon mediates liver gene transfer. Cell 132:397\u2013409","journal-title":"Cell"},{"key":"20_CR13","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1073\/pnas.97.3.1002","volume":"97","author":"V Sandig","year":"2000","unstructured":"Sandig V, Youil R, Bett AJ, Franlin LL, Oshima M, Maione D, Wang F, Metzker ML, Savino R, Caskey CT (2000) Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc Natl Acad Sci U S A 97:1002\u20131007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"20_CR14","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1128\/jvi.71.3.1842-1849.1997","volume":"71","author":"S Hardy","year":"1997","unstructured":"Hardy S, Kitamura M, Harris-Stansil T, Dai Y, Phipps ML (1997) Construction of adenovirus vectors through Cre-lox recombination. J Virol 71:1842\u20131849","journal-title":"J Virol"},{"key":"20_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0166-0934(97)00129-8","volume":"68","author":"R Alemany","year":"1997","unstructured":"Alemany R, Dai Y, Lou YC, Sethi E, Prokopenko E, Josephs SF, Zhang WW (1997) Complementation of helper-dependent adenoviral vectors: size effects and titer fluctuations. J Virol Methods 68:147\u2013159","journal-title":"J Virol Methods"},{"key":"20_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.virusres.2006.02.001","volume":"119","author":"D Majhen","year":"2006","unstructured":"Majhen D, Ambriovic-Ristov A (2006) Adenoviral vectors\u2014how to use them in cancer gene therapy? Virus Res 119:121\u2013133","journal-title":"Virus Res"},{"key":"20_CR17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S0958-1669(99)00007-5","volume":"10","author":"K Benihoud","year":"1999","unstructured":"Benihoud K, Yeh P, Perricaudet M (1999) Adenovirus vectors for gene delivery. Curr Opin Biotechnol 10:440\u2013447","journal-title":"Curr Opin Biotechnol"},{"issue":"2","key":"20_CR18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/mt.2008.257","volume":"17","author":"Nicola Brunetti-Pierri","year":"2009","unstructured":"Brunetti-Pierri N, Stapleton GE, Law M, Breinholt J, Palmer DJ, Zuo Y, Grove NC, Finegold MJ, Rice K, Beaudet al, Mullins CE, Ng P (2009) Efficient, long-term hepatic gene transfer using clinically relevant HDAd doses by balloon occlusion catheter delivery in nonhuman primates. Mol Ther 17:327\u2013333","journal-title":"Molecular Therapy"},{"issue":"2","key":"20_CR19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/mthe.2002.0532","volume":"5","author":"Gabriele Toietta","year":"2002","unstructured":"Toietta G, Pastore L, Cerullo V, Finegold M, Beaudet al, Lee B (2002) Generation of helper-dependent adenoviral vectors by homologous recombination. Mol Ther 5:204\u2013210","journal-title":"Molecular Therapy"},{"key":"20_CR20","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1517\/17425247.2010.533655","volume":"7","author":"MB Mowa","year":"2010","unstructured":"Mowa MB, Crowther C, Arbuthnot P (2010) Therapeutic potential of adenoviral vectors for delivery of expressed RNAi activators. Expert Opin Drug Deliv 7:1373\u20131385","journal-title":"Expert Opin Drug Deliv"},{"key":"20_CR21","first-page":"33","volume-title":"Methods in Molecular Biology","author":"Donna J. Palmer","year":"2008","unstructured":"Palmer DN, Ng P (2008) Methods for the production of helper dependent adenoviral vectors. In: LeDoux J (ed) Gene therapy protocols, vol 433, Methods in molecular biology. Springer, New York, pp 33\u201354"},{"key":"20_CR22","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/jgm.867","volume":"8","author":"CX Shi","year":"2006","unstructured":"Shi CX, Graham FL, Hitt MM (2006) A convenient plasmid system for construction of helper-dependent adenoviral vectors and its application for analysis of the breast-cancer-specific mammaglobin promoter. J Gene Med 8:442\u2013451","journal-title":"J Gene Med"},{"key":"20_CR23","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1006\/mthe.2001.0323","volume":"3","author":"P Ng","year":"2001","unstructured":"Ng P, Beauchamp C, Evelegh C, Parks R, Graham FL (2001) Development of a FLP\/frt system for generating helper-dependent adenoviral vectors. Mol Ther 3:809\u2013815","journal-title":"Mol Ther"},{"key":"20_CR24","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ymthe.2003.08.014","volume":"8","author":"D Palmer","year":"2003","unstructured":"Palmer D, Ng P (2003) Improved system for helper-dependent adenoviral vector production. Mol Ther 8:846\u2013852","journal-title":"Mol Ther"},{"key":"20_CR26","first-page":"371","volume":"69","author":"P Ng","year":"2002","unstructured":"Ng P, Parks RJ, Graham FL (2002) Preparation of helper-dependent adenoviral vectors. Methods Mol Med 69:371\u2013388","journal-title":"Methods Mol Med"},{"key":"20_CR27","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.ymthe.2004.06.1013","volume":"10","author":"DJ Palmer","year":"2004","unstructured":"Palmer DJ, Ng P (2004) Physical and infectious titers of helper-dependent adenoviral vectors: a method of direct comparison to the adenovirus reference material. Mol Ther 10:792\u2013798","journal-title":"Mol Ther"},{"key":"20_CR28","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/11400","volume":"5","author":"C Nyberg-Hoffman","year":"1999","unstructured":"Nyberg-Hoffman C, Aguilar-Cordova E (1999) Instability of adenoviral vectors during transport and its implication for clinical studies. Nat Med 5:955\u2013957","journal-title":"Nat Med"},{"key":"20_CR29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/B978-044450986-4\/50069-2","volume-title":"Frontiers in Viral Hepatitis","author":"P.L. Marion","year":"2003","unstructured":"Marion PL, Salazar FH, Liittschwager K, Bordier BB, Seegers C, Winters MA, Cooper AD, Cullen JM (2003) A transgenic mouse lineage useful for testing antivirals targeting hepatitis B virus. In: Schinazi R, Sommadossi J-R and Rice C.M. (eds) Frontiers in viral hepatitis. Elsevier Science, Amsterdam, pp 197\u2013202"}],"container-title":["Methods in Molecular Biology","SiRNA Delivery Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3112-5_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T14:14:02Z","timestamp":1674224042000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4939-3112-5_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493931118","9781493931125"],"references-count":28,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3112-5_20","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4939-3112-5","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}